Fox Chase Cancer Center - Philadelphia — Philadelphia, Pennsylvania

Fox Chase Cancer Center - Philadelphia is a clinical research site located in Philadelphia, Pennsylvania, United States 19111-2497.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Fox Chase Cancer Center - Philadelphia has participated in 112 clinical trials with 11 currently active.

Therapeutic areas: Head and Neck Cancer, Lymphoma, Osteoporosis.

Sponsors: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fox Chase Cancer Center - Philadelphia?

Fox Chase Cancer Center - Philadelphia has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fox Chase Cancer Center - Philadelphia conducted?

Fox Chase Cancer Center - Philadelphia has 112 clinical trials on record, with 11 currently active. Their work covers Head and Neck Cancer, Lymphoma, Osteoporosis.

Is Fox Chase Cancer Center - Philadelphia accredited by Crixeo Health?

Fox Chase Cancer Center - Philadelphia has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fox Chase Cancer Center - Philadelphia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.